• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT / ST. JUDE MEDICAL, INC. TRIFECTA 23 AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT / ST. JUDE MEDICAL, INC. TRIFECTA 23 AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Patient Problem Unspecified Infection (1930)
Event Date 02/28/2023
Event Type  Injury  
Event Description
(b)(6), 2017 had aortic valve surgery with trifecta 23 aortic valve.Two weeks later, additional surgery required, had infection and doctor.Removed sternum.Had to have tavr(transcatheter aortic valve replacement) to replace the trifecta 23 on (b)(6) 2023 due to issues with trifecta valve.This is just a glimpse of what i have been through since my 1st savr in 2017.Please feel free to contact us if you have any questions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA 23 AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT / ST. JUDE MEDICAL, INC.
MDR Report Key17624423
MDR Text Key322105530
Report NumberMW5144960
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age71 YR
Patient SexMale
Patient Weight136 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-